Entera Bio (ENTX) Institutional Ownership $1.55 -0.08 (-4.91%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Entera Bio (NASDAQ:ENTX)CurrentInstitutional OwnershipPercentage14.11%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$144.89KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$31.83K Get ENTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Entera Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENTX Institutional Buying and Selling by Quarter Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Entera Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Parkman Healthcare Partners LLC411,076$781K0.1%+2.4%1.149% 11/6/2024 Signature Estate & Investment Advisors LLC47,328$90K0.0%N/A0.132% 8/9/2024 Renaissance Technologies LLC57,600$106K0.0%-23.1%0.161% 5/20/2024Virtu Financial LLC22,040$37K0.0%N/A0.000% 2/14/2023 RA Capital Management L.P.295,966$216K0.0%-85.8%1.028% 11/14/2022 RA Capital Management L.P.2,082,372$2.17M0.0%-11.5%7.229% 1/31/2022Altium Wealth Management LLC11,830$33K0.0%N/A0.050% 1/28/2022 ARK Investment Management LLC690,922$1.95M0.0%+1.2%2.915% 8/17/2021 Knoll Capital Management LLC2,484,275$14.86M7.8%+38.7%10.482% 8/16/2021 RA Capital Management L.P.2,353,000$14.07M0.2%N/A9.928% 8/13/2021 Geode Capital Management LLC17,597$105K0.0%N/A0.074% 8/11/2021Susquehanna Fundamental Investments LLC14,400$86K0.0%N/A0.061% 6/14/2021 Knoll Capital Management LLC1,791,363$6.83M4.4%+2.9%7.558% 5/18/2021 Millennium Management LLC38,611$147K0.0%N/A0.163% 5/14/2021 XTX Topco Ltd11,559$44K0.0%N/A0.101% 5/13/2021 Renaissance Technologies LLC120,407$459K0.0%+66.8%1.053% 2/24/2021Virtu Financial LLC31,314$34K0.0%N/A0.274% 2/10/2021 Renaissance Technologies LLC72,186$78K0.0%N/A0.632% (Data available from 1/1/2016 forward) ENTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Entera Bio shares: Parkman Healthcare Partners LLC ($781K), RA Capital Management L.P. ($216K), Renaissance Technologies LLC ($106K), and Signature Estate & Investment Advisors LLC ($90K), Virtu Financial LLC ($37K).Learn more on ENTX's institutional investors. What percentage of Entera Bio stock is owned by institutional investors? 14.11% of Entera Bio stock is owned by institutional investors. Learn more on ENTX's institutional investor holdings. Which institutional investors have been buying Entera Bio stock? The following institutional investors have purchased Entera Bio stock in the last 24 months: Signature Estate & Investment Advisors LLC ($47.33K), Virtu Financial LLC ($22.04K), and Parkman Healthcare Partners LLC ($9.56K). How much institutional buying is happening at Entera Bio? Institutional investors have bought a total of 78,926 shares in the last 24 months. This purchase volume represents approximately $144.89K in transactions. Which Entera Bio major shareholders have been selling company stock? The following institutional investors have sold Entera Bio stock in the last 24 months: RA Capital Management L.P. ($1.79M), and Renaissance Technologies LLC ($17.30K). How much institutional selling is happening at Entera Bio? Institutional investors have sold a total of 1,803,706 shares in the last 24 months. This volume of shares sold represents approximately $1.34M in transactions. Related Companies Aurora Cannabis Institutional Ownership Trevi Therapeutics Institutional Ownership Biomea Fusion Institutional Ownership TScan Therapeutics Institutional Ownership Sutro Biopharma Institutional Ownership Cybin Institutional Ownership MacroGenics Institutional Ownership SOPHiA GENETICS Institutional Ownership Zentalis Pharmaceuticals Institutional Ownership Genfit Institutional Ownership This page (NASDAQ:ENTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
